Browse the full record of transactions filed by 于海生, Director. Insider active across 1 company, notably 英科医疗. In total, 33 disclosures have been logged. Regulator: SSE / SZSE (CSRC). The full history is accessible without signup.
Declarations 33 total
● 董事,高管 · Executives · 4 Dec 2025 · 百普赛斯 5,900 shares A股 SZSE:173000009867117900 ● 董事,高管 · Executives · 3 Dec 2025 · 百普赛斯 6,300 shares A股 SZSE:173000009860701820 ● 董秘,高管 · Executives · 13 Oct 2025 · 百普赛斯 9,300 shares A股 SZSE:173000009628394560 ● 董秘,高管 · Executives · 10 Oct 2025 · 百普赛斯 11,800 shares A股 SZSE:173000009625471900 ● 董事 · Executives · 7 Jul 2025 · 九洲集团 20,000 shares A股 SZSE:173000009171309200 ● 董事,高管 · Executives · 25 Nov 2024 · 仙乐健康 2,100,000 shares A股 SZSE:173000008295273920 ● 董事,高管 · Executives · 15 Aug 2024 · 仙乐健康 15,900 shares A股 SZSE:173000007961467800 Ideal exit: 12 May 2025 (T+270) ● 董事,高管 · Executives · 14 Aug 2024 · 仙乐健康 6,800 shares A股 SZSE:173000007956696160 Ideal exit: 11 May 2025 (T+270) ● 董事 · Executives · 22 Mar 2024 · 英科医疗 121,000 shares A股 SZSE:173000007417101060 Ideal exit: 17 Dec 2024 (T+270) ● 董事 · Executives · 27 May 2022 · 九洲集团 181,000 shares A股 SZSE:173000009655466000 Ideal exit: 21 Feb 2023 (T+270) ● 董事 · Executives · 24 May 2022 · 九洲集团 559,200 shares A股 SZSE:173000009655464600 Ideal exit: 18 Feb 2023 (T+270) ● 董事 · Executives · 17 May 2022 · 九洲集团 49,600 shares A股 SZSE:173000009655462850 Ideal exit: 11 Feb 2023 (T+270) ● 董事 · Executives · 16 May 2022 · 九洲集团 327,000 shares A股 SZSE:173000009655461470 Ideal exit: 10 Feb 2023 (T+270) ● 董事 · Executives · 13 May 2022 · 九洲集团 362,800 shares A股 SZSE:173000009655458800 Ideal exit: 7 Feb 2023 (T+270) ● 董事 · Executives · 12 May 2022 · 九洲集团 31,300 shares A股 SZSE:173000009655453340 Ideal exit: 6 Feb 2023 (T+270) ● 高级管理人员 · Executives · 13 Jan 2022 · 昂立教育 2,000 shares A股 SSE:173000005220655700 ● 董事长 · Executives · 12 Nov 2021 · 英科医疗 2,242,050 shares A股 SZSE:173000005069817150 ● 董事 · Executives · 13 Oct 2021 · 昂立教育 100 shares A股 SSE:173000004974899000 ● 监事 · Executives · 11 Oct 2021 · 昂立教育 9,400 shares A股 SSE:173000004974898980 Ideal exit: 8 Jul 2022 (T+270) ● 董事 · Executives · 8 Oct 2021 · 昂立教育 100 shares A股 SSE:173000004967629660 ● 董事 · Executives · 30 Jul 2021 · 英科医疗 63,000 shares A股 SZSE:173000004609545250 ● 董事,总经理 · Executives · 30 Jul 2021 · 英科医疗 10,000 shares A股 SZSE:173000005688670140 ● 董事长 · Executives · 29 Jul 2021 · 英科医疗 547,163 shares A股 SZSE:173000004609545200 ● 副总经理,董事会秘书 · Executives · 28 Jul 2021 · 英科医疗 40,400 shares A股 SZSE:173000004604146300 ● 董事,高管 · Executives · 20 Jul 2021 · 仙乐健康 7,200 shares A股 SZSE:173000004629073660 25 of 33 declarations
Load more (8 remaining) About 于海生 Yu Haisheng is a director and executive at Yingke Medical. He is involved in the strategic direction of the company and oversees operations to ensure growth objectives are met. His expertise in the healthcare sector enables him to guide the company towards new opportunities.